Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lorena Sanchez Felipe"'
Autor:
Sapna Sharma, Michael A. Schmid, Lorena Sanchez Felipe, Jana Grenelle, Suzanne J.F. Kaptein, Lotte Coelmont, Johan Neyts, Kai Dallmeier
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 9, Pp 2196-2203 (2020)
Plasmid-launched live-attenuated vaccines (PLLAV), also called infectious DNA (iDNA) vaccines, combine the assets of genetic immunization with the potency of replication-competent live viral vaccines. However, due to their origin as bacterial plasmid
Externí odkaz:
https://doaj.org/article/5b8805ccbb5345fb9cd960384c55a83f
Autor:
Sapna Sharma, Thomas Vercruysse, Lorena Sanchez-Felipe, Winnie Kerstens, Madina Rasulova, Lindsey Bervoets, Carolien De Keyzer, Rana Abdelnabi, Caroline S. Foo, Viktor Lemmens, Dominique Van Looveren, Piet Maes, Guy Baele, Birgit Weynand, Philippe Lemey, Johan Neyts, Hendrik Jan Thibaut, Kai Dallmeier
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Currently licensed COVID-19 vaccines are based on antigen sequences of early SARS-CoV-2 isolates, despite the prevalence of variants of concerns escaping vaccine-mediated protection. Using their updated yellow fever 17D vectored candidate, here, auth
Externí odkaz:
https://doaj.org/article/4924ff2c0d8d4311b6386793aa74eaa2
Autor:
Ji Ma, Michael Bright Yakass, Sander Jansen, Bert Malengier-Devlies, Dominique Van Looveren, Lorena Sanchez-Felipe, Thomas Vercruysse, Birgit Weynand, Mahadesh Prasad Arkalagud Javarappa, Osbourne Quaye, Patrick Matthys, Tania Roskams, Johan Neyts, Hendrik Jan Thibaut, Kai Dallmeier
Publikováno v:
EBioMedicine, Vol 83, Iss , Pp 104240- (2022)
Summary: Background: The live-attenuated yellow fever vaccine YF17D holds great promise as alternative viral vector vaccine platform, showcased by our previously presented potent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine ca
Externí odkaz:
https://doaj.org/article/270dca2fe4d84600b4955f812e5c5bb0
Autor:
Ji Ma, Robbert Boudewijns, Lorena Sanchez-Felipe, Niraj Mishra, Thomas Vercruysse, Dieudonné Buh Kum, Hendrik Jan Thibaut, Johan Neyts, Kai Dallmeier
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 2279-2290 (2021)
The live-attenuated yellow fever 17D (YF17D) vaccine is one of the most efficacious human vaccines and also employed as a vector for novel vaccines. However, in the lack of appropriate immunocompetent small animal models, mechanistic insight in YF17D
Externí odkaz:
https://doaj.org/article/cbeaf788d7754508ab04743ef8ddbea9
Autor:
Rana Abdelnabi, Robbert Boudewijns, Caroline S. Foo, Laura Seldeslachts, Lorena Sanchez-Felipe, Xin Zhang, Leen Delang, Piet Maes, Suzanne J.F. Kaptein, Birgit Weynand, Greetje Vande Velde, Johan Neyts, Kai Dallmeier
Publikováno v:
EBioMedicine, Vol 68, Iss , Pp 103403- (2021)
Background: Within one year after its emergence, more than 108 million people acquired SARS-CoV-2 and almost 2·4 million succumbed to COVID-19. New SARS-CoV-2 variants of concern (VoC) are emerging all over the world, with the threat of being more r
Externí odkaz:
https://doaj.org/article/ee564667283f4a5b96d422846fde7095
Autor:
Viktor Lemmens, Lara Kelchtermans, Sarah Debaveye, Winston Chiu, Thomas Vercruysse, Ji Ma, Hendrik Jan Thibaut, Johan Neyts, Lorena Sanchez-Felipe, Kai Dallmeier
Ebola virus (EBOV) and related filoviruses such as Sudan virus (SUDV) threaten global public health. Effective filovirus vaccines are available only for EBOV, yet restricted to emergency use considering a high reactogenicity and demanding logistics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e134a9b548a9aca498b655c5c491a1d0
https://doi.org/10.1101/2023.01.13.523888
https://doi.org/10.1101/2023.01.13.523888
Autor:
Robbert Boudewijns, Ji Ma, Lorena Sanchez-Felipe, Dieudonné Buh Kum, Johan Neyts, Kai Dallmeier, Niraj Mishra, Hendrik Jan Thibaut, Thomas Vercruysse
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
The live-attenuated yellow fever 17D (YF17D) vaccine is one of the most efficacious human vaccines and also employed as a vector for novel vaccines. However, in the lack of appropriate immunocompetent small animal models, mechanistic insight in YF17D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea7ef66539616895e686b688d703cea8
https://doi.org/10.1080/22221751.2021.2008772
https://doi.org/10.1080/22221751.2021.2008772
Autor:
Laura Seldeslachts, Christopher Cawthorne, Suzanne F. Kaptein, Robbert Boudewijns, Hendrik Jan Thibaut, Lorena Sanchez Felipe, Sapna Sharma, Georg Schramm, Birgit Weynand, Kai Dallmeier, Greetje Vande Velde
Publikováno v:
Vaccine Design ISBN: 9781071618837
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff949a49b33613287eaa49bed230e8ad
https://doi.org/10.1007/978-1-0716-1884-4_8
https://doi.org/10.1007/978-1-0716-1884-4_8
Autor:
Laura, Seldeslachts, Christopher, Cawthorne, Suzanne F, Kaptein, Robbert, Boudewijns, Hendrik Jan, Thibaut, Lorena, Sanchez Felipe, Sapna, Sharma, Georg, Schramm, Birgit, Weynand, Kai, Dallmeier, Greetje, Vande Velde
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2410
The SARS-CoV-2 pandemic has impacted the health of humanity after the outbreak in Hubei, China in late December 2019. Ever since, it has taken unprecedented proportions and rapidity causing over a million fatal cases. Recently, a robust Syrian golden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::295622363f53f6dcfe3ff0125630cb25
https://pubmed.ncbi.nlm.nih.gov/34914047
https://pubmed.ncbi.nlm.nih.gov/34914047
Autor:
Sapna Sharma, Thomas Vercruysse, Lorena Sanchez-Felipe, Winnie Kerstens, Madina Rasulova, Rana Abdelnabi, Caroline S Foo, Viktor Lemmens, Dominique Van Looveren, Piet Maes, Guy Baele, Birgit Weynand, Philippe Lemey, Johan Neyts, Hendrik Jan Thibaut, Kai Dallmeier
Current first-generation COVID-19 vaccines are based on prototypic spike sequences from ancestral 2019 SARS-CoV-2 strains. However, the ongoing pandemic is fueled by variants of concern (VOC) that threaten to escape vaccine-mediated protection. Here
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5a45bb81e90775d96e0f1ea890c2820
https://doi.org/10.1101/2021.11.12.468374
https://doi.org/10.1101/2021.11.12.468374